Immediate Impact

4 standout
Sub-graph 1 of 2

Citing Papers

Multiple myeloma
2024 Standout
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel
2023 Standout
2 intermediate papers

Works of Ali Rismani being referenced

Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design
2020
Outcome of Pomalidomide Therapy in Relapsed /Refractory Myeloma: A Uk Multi-Centre Experience
2015

Author Peers

Author Last Decade Papers Cites
Ali Rismani 131 52 90 55 25 215
Dubravka Sertić 60 60 87 50 22 247
Anna Christoforidou 98 55 50 64 29 222
Yuliya Linhares 92 41 91 75 27 273
Benedikt Wagner 118 23 69 64 19 271
Jean‐Pierre Vilque 77 44 126 26 18 250
Elizabeth H. Cull 111 18 96 97 27 259
Irena Đjunić 213 72 59 80 30 284
Árpád Szomor 91 64 79 35 31 258
Ken Furudate 140 39 80 81 28 281
Silvana Bonfigli 169 114 45 23 22 293

All Works

Loading papers...

Rankless by CCL
2026